tiprankstipranks
Trending News
More News >
Clearside Biomedical (CLSDQ)
OTHER OTC:CLSDQ
US Market

Clearside Biomedical (CLSDQ) Stock Forecast & Price Target

Compare
1,067 Followers
See the Price Targets and Ratings of:

CLSDQ Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Clearside
Biomedical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CLSDQ Stock 12 Month Forecast

There Are No Analyst Ratings for CLSDQ In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

CLSDQ Financial Forecast

CLSDQ Earnings Forecast

Next quarter’s earnings estimate for CLSDQ is -$0.60 with a range of -$0.60 to -$0.60. The previous quarter’s EPS was -$17.10. CLSDQ beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year CLSDQ has Performed in-line its overall industry.
Next quarter’s earnings estimate for CLSDQ is -$0.60 with a range of -$0.60 to -$0.60. The previous quarter’s EPS was -$17.10. CLSDQ beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year CLSDQ has Performed in-line its overall industry.

CLSDQ Sales Forecast

Next quarter’s sales forecast for CLSDQ is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $201.00K. CLSDQ beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year CLSDQ has Performed in-line its overall industry.
Next quarter’s sales forecast for CLSDQ is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $201.00K. CLSDQ beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year CLSDQ has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
JonesTrading
Hold
Reiterated
08/11/25
Hold Rating on Clearside Biomedical Amid Financial Uncertainty and Strategic Exploration
H.C. Wainwright Analyst forecast on CLSDQ
H.C. Wainwright
H.C. Wainwright
Hold
Downgraded
07/18/25
Clearside Biomedical downgraded to Neutral from Buy at H.C. WainwrightClearside Biomedical downgraded to Neutral from Buy at H.C. Wainwright
Citizens JMP Analyst forecast on CLSDQ
Citizens JMP
Citizens JMP
Hold
Downgraded
07/17/25
Citizens JMP downgrades Clearside Biomedical (CLSD) to a Hold
Chardan Capital Analyst forecast on CLSDQ
Chardan Capital
Chardan Capital
Hold
Downgraded
07/17/25
Clearside Biomedical (CLSD) was downgraded to a Hold Rating at Chardan Capital
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
JonesTrading
Hold
Reiterated
08/11/25
Hold Rating on Clearside Biomedical Amid Financial Uncertainty and Strategic Exploration
H.C. Wainwright Analyst forecast on CLSDQ
H.C. Wainwright
H.C. Wainwright
Hold
Downgraded
07/18/25
Clearside Biomedical downgraded to Neutral from Buy at H.C. WainwrightClearside Biomedical downgraded to Neutral from Buy at H.C. Wainwright
Citizens JMP Analyst forecast on CLSDQ
Citizens JMP
Citizens JMP
Hold
Downgraded
07/17/25
Citizens JMP downgrades Clearside Biomedical (CLSD) to a Hold
Chardan Capital Analyst forecast on CLSDQ
Chardan Capital
Chardan Capital
Hold
Downgraded
07/17/25
Clearside Biomedical (CLSD) was downgraded to a Hold Rating at Chardan Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Clearside Biomedical

3 Months
xxx
Success Rate
2/3 ratings generated profit
67%
Average Return
+9.20%
upgraded a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +9.20% per trade.
1 Year
DeepSeek BiotechnologyTipRanks - DeepSeek
Success Rate
2/3 ratings generated profit
67%
Average Return
+9.20%
upgraded a sell rating 20 days ago
Copying DeepSeek Biotechnology's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +9.20% per trade.
2 Years
xxx
Success Rate
2/3 ratings generated profit
67%
Average Return
+9.20%
upgraded a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +9.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CLSDQ Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
10
19
23
27
18
Sell
0
13
25
60
56
Strong Sell
6
3
1
4
4
total
16
35
49
91
78
In the current month, CLSDQ has received 0 Buy Ratings, 18 Hold Ratings, and 60 Sell Ratings. CLSDQ average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

CLSDQ Stock Forecast FAQ

What is CLSDQ’s average 12-month price target, according to analysts?
Currently, no data Available
What is CLSDQ’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CLSDQ, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is CLSDQ a Buy, Sell or Hold?
      Currently, no data Available
      What is Clearside Biomedical’s price target?
      Currently, no data Available
      What do analysts say about Clearside Biomedical?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of CLSDQ?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.